Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers

U Quast, KM Bray, H Andres, PW Manley, Y Baumlin and J Dosogne

Sandoz Pharma Ltd., Basel, Switzerland.

P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N"-3-pyridylguanidine], an analogue of the K+ channel opener pinacidil, was shown to be a K+ channel opener in rat aorta, based on (i) its ability to stimulate 86Rb+ efflux, (ii) its ability to relax contractions in response to noradrenaline under normal conditions (5 mM KCl) but not under depolarized conditions (55 mM KCl), and (iii) the sensitivity of these effects to inhibition by the sulfonylurea glibenclamide. In these assays, P1075 was approximately 20 times more potent than cromakalim. Using a tritiated derivative, [3H] P1075, specific binding could not be detected in microsomal preparations from various tissues. However, in rat aortic strips specific binding of [3H]P1075 has been observed and was reduced by lowering the temperature or by decreasing intracellular ATP levels via metabolic inhibition. Specific [3H]P1075 binding was influenced neither by depolarization (55 mM KCl) nor by lowering the pH from 7.4 to 6.0. Binding was inhibited by representatives from all major families of K+ channel openers, with potencies that correlated well with the potencies obtained in 86Rb+ efflux and relaxation studies. However, stimulation of 86Rb+ efflux occurred at 40 times higher concentrations than did binding (and vasorelaxation). Of the various inhibitors of the K+ channel openers tested, only the sulfonylureas inhibited [3H] P1075 binding with the same rank order of potencies as that required for inhibition of P1075-induced 86Rb+ efflux, although at higher concentrations. The results show that binding of [3H] P1075 is independent of membrane potential but decreases concomitantly with the intracellular ATP level. The excellent correlation between the potencies of the openers and sulfonylurea blockers in binding assays and functional studies suggests that the 'drug receptor' labeled by [3H]P1075 in rat isolated aorta is of functional relevance. However, the fact that binding of the openers occurred at concentrations considerably lower than those required for K+ channel opening and that binding of the sulfonylureas was only reflected at concentrations higher than those needed to block the channel requires complex models to link binding and effect, possibly involving two agonist binding sites coupled by negative cooperativity.

Volume 43, Issue 3, pp. 474-481, 03/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				U. Lange, C. Loffler-Walz, H. C. Englert, A. Hambrock, U. Russ, and U. Quast The Stereoenantiomers of a Pinacidil Analog Open or Close Cloned ATP-sensitive K+ Channels J. Biol. Chem., October 18, 2002; 277(43): 40196 - 40205. [Abstract] [Full Text] [PDF]

				A. Hambrock, R. Preisig-Muller, U. Russ, A. Piehl, P. J. Hanley, J. Ray, J. Daut, U. Quast, and C. Derst Four novel splice variants of sulfonylurea receptor 1 Am J Physiol Cell Physiol, August 1, 2002; 283(2): C587 - C598. [Abstract] [Full Text] [PDF]

				C. Loffler-Walz, A. Hambrock, and U. Quast Interaction of KATP Channel Modulators with Sulfonylurea Receptor SUR2B: Implication for Tetramer Formation and Allosteric Coupling of Subunits Mol. Pharmacol., February 1, 2002; 61(2): 407 - 414. [Abstract] [Full Text] [PDF]

				U. Russ, U. Lange, C. Loffler-Walz, A. Hambrock, and U. Quast Interaction of the Sulfonylthiourea HMR 1833 with Sulfonylurea Receptors and Recombinant ATP-Sensitive K+ Channels: Comparison with Glibenclamide J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1049 - 1055. [Abstract] [Full Text] [PDF]

				C.-C. Shieh, J. Feng, S. A. Buckner, J. D. Brioni, M. J. Coghlan, J. P. Sullivan, and M. Gopalakrishnan Functional Implication of Spare ATP-Sensitive K+ Channels in Bladder Smooth Muscle Cells J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 669 - 675. [Abstract] [Full Text]

				U. Russ, A. Hambrock, F. Artunc, C. Löffler-Walz, Y. Horio, Y. Kurachi, and U. Quast Coexpression with the Inward Rectifier K+ Channel Kir6.1 Increases the Affinity of the Vascular Sulfonylurea Receptor SUR2B for Glibenclamide Mol. Pharmacol., November 1, 1999; 56(5): 955 - 961. [Abstract] [Full Text]

				I. Uhde, A. Toman, I. Gross, C. Schwanstecher, and M. Schwanstecher Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors J. Biol. Chem., October 1, 1999; 274(40): 28079 - 28082. [Abstract] [Full Text] [PDF]

				H. Dörschner, I. Uhde, C. Schwanstecher, and M. Schwanstecher Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure Mol. Pharmacol., June 1, 1999; 55(6): 1060 - 1066. [Abstract] [Full Text]

				A. Hambrock, C. Löffler-Walz, D. Kloor, U. Delabar, Y. Horio, Y. Kurachi, and U. Quast ATP-Sensitive K+ Channel Modulator Binding to Sulfonylurea Receptors SUR2A and SUR2B: Opposite Effects of MgADP Mol. Pharmacol., May 1, 1999; 55(5): 832 - 840. [Abstract] [Full Text]

				M. Gopalakrishnan, K. L. Whiteaker, E. J. Molinari, R. Davis-Taber, V. E. S. Scott, C.-C. Shieh, S. A. Buckner, I. Milicic, J. C. Cain, S. Postl, et al. Characterization of the ATP-Sensitive Potassium Channels (KATP) Expressed in Guinea Pig Bladder Smooth Muscle Cells J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 551 - 558. [Abstract] [Full Text]

				S. A. Khan, N. R. Higdon, J. B. Hester, and K. D. Meisheri Pharmacological Characterization of Novel Cyanoguanidines as Vascular KATP Channel Blockers J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1207 - 1213. [Abstract] [Full Text]

				K. E. J. Dickinson, C. C. Bryson, R. B. Cohen, L. Rogers, D. W. Green, and K. S. Atwal Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes Mol. Pharmacol., September 1, 1997; 52(3): 473 - 481. [Abstract] [Full Text]

				N. R. Higdon, S. A. Khan, L. V. Buchanan, and K. D. Meisheri Tissue and Species Variation in the Vascular Receptor Binding of 3H-P1075, a Potent KATP Opener Vasodilator J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 255 - 260. [Abstract] [Full Text]

				T. Kitazono, F. M. Faraci, H. Taguchi, and D. D. Heistad Role of Potassium Channels in Cerebral Blood Vessels Stroke, September 1, 1995; 26(9): 1713 - 1723. [Abstract] [Full Text]